YOLFTbeta
Envoy Medical Inc.

Envoy Medical Inc.

COCH · NASDAQ · Healthcare / Medical Devices

6.74USD-0.07 (-1.10%)

Price History

Full chart

Market Stats

Previous Close6.81
Open6.60
Day Range6.50 – 6.92
52-Week Range0.363 – 1.89
Volume10.02K
Market Cap55.19M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.76
Dividend Yield0.00%
Beta1.90
50-Day Avg0.7106
200-Day Avg0.6961

About

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Brent T. Lucas Esq.
  • Employees43
  • Headquarters4875 White Bear Parkway, White Bear Lake, MN, United States, 55110, USA
  • Websitehttps://www.envoymedical.com

Leadership

  • Mr. Brent T. Lucas Esq.CEO & Director · b. 1982
  • Mr. Robert M. PotashnickChief Accounting Officer, VP of Finance, Principal Financial Officer & Principal Accounting Officer · b. 1981
  • Ms. Karin SimonsonVP, General Counsel & Corporate Secretary

Financials

Income Statement

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-310.00K237.00K316.00K225.00K241.00K
Growth (%)---23.55%+33.33%-28.80%+7.11%
Cost of Revenue-769.00K498.00K789.00K742.00K874.00K
Gross Profit--459.00K-261.00K-473.00K-517.00K-633.00K
Gross Margin--148.06%-110.13%-149.68%-229.78%-262.66%
Operating Expense-6.41M8.45M17.89M18.74M21.64M
Operating Income-701-6.87M-8.71M-18.36M-19.26M-22.27M
Operating Margin--2216.45%-3673.42%-5809.81%-8558.22%-9240.66%
EBITDA-701-8.60M-15.85M-29.79M-19.81M-21.86M
EBITDA Margin--2775.48%-6686.92%-9426.90%-8802.67%-9072.20%
Net Income-701-8.68M-15.92M-29.92M-20.80M-23.76M
Net Income Margin--2798.39%-6718.57%-9468.99%-9242.22%-9857.26%
R&D-3.94M4.97M8.96M10.18M12.49M
R&D as % of Total Revenue-1270.65%2099.16%2834.18%4524.00%5180.91%
Interest Expense---0816.00K1.59M
Interest Expense % of Total Revenue---0.00%362.67%659.75%

Balance Sheet

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets119.99K2.62M2.56M8.27M11.54M8.56M
Total Liabilities95.69K47.58M38.75M10.05M30.38M20.32M
Total Equity24.30K-44.96M-36.20M-1.78M-18.84M-11.77M
Cash25.00K1.12M183.00K4.22M5.48M3.74M
Total Debt-23.48M34.53M562.00K19.66M919.00K
Net Debt-25.00K22.36M34.35M-3.66M14.18M-2.82M

Cash Flow

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.94M-8.80M-17.09M-17.95M-18.20M
Investing Cash Flow-125.00K-218.00K-153.00K-980.00K-179.00K
Financing Cash Flow8.06M8.09M21.28M20.20M16.63M
Capital Expenditure125.00K218.00K153.00K980.00K179.00K
Free Cash Flow-7.06M-9.02M-17.24M-18.93M-18.38M
Dividends Paid--02.45M1.82M
FCF to OCF101.80%102.48%100.90%105.46%100.98%
Dividend Paid to FCF--0.00%-12.93%-9.90%

Earnings

Report DateMay 17, 2021Aug 18, 2021Nov 12, 2021Mar 31, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Dec 31, 2022Apr 3, 2023Aug 30, 2023Nov 17, 2023Dec 31, 2023May 15, 2024Aug 12, 2024Nov 14, 2024Mar 31, 2025May 1, 2025Jul 31, 2025Nov 10, 2025Mar 23, 2026May 11, 2026Aug 10, 2026Nov 9, 2026
EPS Estimate0.00-----------0.19-0.26-0.25-0.27-0.31-0.20-0.29-0.29--0.14-0.09-0.07
EPS Actual-0.030.010.10-0.090.230.060.11-0.04-0.04-0.080.13-0.39-0.32-0.27-0.37-0.46-0.29-0.32-0.35-0.27-0.08-0.07-
Surprise------------105.26%-23.08%-8.00%-37.04%-48.39%-45.00%-10.34%-20.69%-42.86%22.22%-
Timing----------After-hours-After-hoursPre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap55.19M
Enterprise Value36.47M
Trailing P/E0.00
Forward P/E0.00
Price / Sales266.64
Price / Book14.98
EPS-0.76
Book Value0.048
Revenue (TTM)207.00K
Gross Profit (TTM)-608.00K
EBITDA-23.13M
Profit Margin0.00%
Operating Margin-10919.61%
Return on Equity0.00%
Return on Assets-86.53%
Shares Outstanding77.19M
Shares Float43.22M
Beta1.90
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 4 analystsTarget 2.00
  • Strong Buy
    4

Ownership Breakdown

Institutions
23.31%
Insiders
40.23%
Retail / Other
36.46%

Top Institutional Holders

  • Nantahala Capital Management, LLC
    7.65M9.88%
  • Bleichroeder LP
    6.25M8.08%
  • Vanguard Capital Management, LLC
    881.67K1.14%
  • Geode Capital Management, LLC
    521.82K0.67%
  • Vanguard Fiduciary Trust Co
    294.72K0.38%
  • The Colony Group LLC
    212.66K0.27%
  • Arcus Capital Partners LLC
    187.57K0.24%
  • Northern Trust Corp
    111.05K0.14%
  • CIBC Bancorp USA Inc.
    77.89K0.10%
  • Morgan Stanley - Brokerage Accounts
    73.90K0.10%
  • UBS Group AG
    70.46K0.09%
  • BlackRock Inc
    47.51K0.06%
  • The Goldman Sachs Group Inc
    36.46K0.05%
  • Susquehanna International Group, LLP
    35.30K0.05%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    273.56K0.35%
  • Fidelity Extended Market Index
    252.60K0.33%
  • Abante Quant Value FI
    135.90K0.18%
  • Fidelity Nasdaq Composite Index
    73.76K0.10%
  • Fidelity Series Total Market Index
    64.96K0.08%
  • Fidelity Total Market Index
    37.41K0.05%

Stock Splits

  • Oct 26, 20261:10